Department of Radiation Oncology
Liver Cancer / Cholangiocarcinoma
-
Technical Advantages
-
Equipment Advantages
-
Leading Experts
Technical Advantages
Technical Advantages
The Department of Radiation Oncology specializes in the precise diagnosis and treatment of liver cancer and cholangiocarcinoma. The technical advantages are as follows
-
Each patient receives a standardized and professional treatment plan developed through a multidisciplinary team (MDT) approach, based on evidence-based medicine. -
Precision radiotherapy techniques, including IMRT, IGRT, VMAT, and respiratory gating, are employed. Based on specific molecular targeted probe examinations (e.g., PSMA PET-CT), irradiation is made more precise, enhancing tumor treatment efficacy while effectively reducing side effects. -
Access to the most advanced proton and heavy ion therapy resources, as well as international consultation services, is provided, enabling patients in need to receive the most advanced and authoritative treatment recommendations and related pathways currently available internationally.
Equipment Advantages
Equipment Advantages
-
1
The latest generation GE Discovery MI PET/CT and NM/CT 870 SPECT/CT systems: These systems achieve comprehensive coverage from molecular imaging diagnosis of genitourinary tumors to routine split renal function (GFR) evaluation. In particular, the application of the novel molecular probe 18F-PSMA (prostate-specific membrane antigen ligand) provides new means for the early diagnosis, initial staging, biochemical recurrence and efficacy evaluation of prostate cancer, as well as the assessment of tumor heterogeneity and biological behavior.
-
2
The world's most advanced Hitachi proton and heavy ion integrated radiotherapy system: Utilizing internationally leading proton and heavy ion technologies, this system leverages the unique "Bragg peak" effect to precisely concentrate radiation energy within the tumor tissue, significantly minimizing damage to normal tissues. It is particularly suitable for pediatric tumors, head and neck tumors, brain tumors, hepatobiliary and pancreatic tumors, and patients with poor radiotherapy tolerance.
-
3
Varian TrueBEAM with HyperArc: The Varian TrueBEAM linear accelerator, equipped with HyperArc technology, enables ultra-high precision stereotactic body radiotherapy (SBRT/SRS). The HyperArc technology can precisely treat multiple tumor lesions in a single session within an extremely short time, making it especially suitable for patients with brain metastases. It significantly improves tumor control rates, reduces the number of treatment sessions, and enhances the patient treatment experience.
-
4
Adaptive Radiotherapy (Adaptive RT): Utilizing cutting-edge adaptive radiotherapy technology, the treatment plan can be adjusted in real-time throughout the radiotherapy course based on changes in tumor morphology and position. Through real-time image monitoring and precise dynamic adjustments, treatment efficacy is effectively enhanced, normal tissues are maximally protected, and each patient receives the most precise and safest treatment experience."
Leading Experts
Lu Jiade
Doctor of Medicine, Master of Management, Professor
Professional Resume
National High-Level Talent, National Distinguished Expert, Chief Scientist of the National Key R&D Program; Professor at Soochow University, Clinical Oncology Professor at Fudan University; Former Executive Vice President of Shanghai Proton and Heavy Ion Hospital, Former Vice President of Singapore General Hospital; Member of the Steering Committee of Heyou International Hospital Group, Vice President of Heyou Hospital; Director of the Oncology Medical Center and Proton and Heavy Ion Center, Heyou Hospital.
Areas of Expertise
Scan WeChat Code to Book
